157 related articles for article (PubMed ID: 18974129)
21. Amplicon profiles in ovarian serous carcinomas.
Nakayama K; Nakayama N; Jinawath N; Salani R; Kurman RJ; Shih IeM; Wang TL
Int J Cancer; 2007 Jun; 120(12):2613-7. PubMed ID: 17351921
[TBL] [Abstract][Full Text] [Related]
22. Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian cancer cells.
Shepherd TG; Thériault BL; Nachtigal MW
Gene; 2008 May; 414(1-2):95-105. PubMed ID: 18372118
[TBL] [Abstract][Full Text] [Related]
23. Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias.
Lee SH; Jeong EG; Yoo NJ; Lee SH
APMIS; 2007 Dec; 115(12):1357-63. PubMed ID: 18184405
[TBL] [Abstract][Full Text] [Related]
24. The roles of Notch3 on the cell proliferation and apoptosis induced by CHIR99021 in NSCLC cell lines: a functional link between Wnt and Notch signaling pathways.
Li C; Zhang S; Lu Y; Zhang Y; Wang E; Cui Z
PLoS One; 2013; 8(12):e84659. PubMed ID: 24367688
[TBL] [Abstract][Full Text] [Related]
25. Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1.
Jung JG; Shih IM; Park JT; Gerry E; Kim TH; Ayhan A; Handschuh K; Davidson B; Fader AN; Selleri L; Wang TL
Cancer Res; 2016 Nov; 76(21):6351-6361. PubMed ID: 27590741
[TBL] [Abstract][Full Text] [Related]
26. PIM-induced phosphorylation of Notch3 promotes breast cancer tumorigenicity in a CSL-independent fashion.
Landor SKJ; Santio NM; Eccleshall WB; Paramonov VM; Gagliani EK; Hall D; Jin SB; Dahlström KM; Salminen TA; Rivero-Müller A; Lendahl U; Kovall RA; Koskinen PJ; Sahlgren C
J Biol Chem; 2021; 296():100593. PubMed ID: 33775697
[TBL] [Abstract][Full Text] [Related]
27. HOX cofactors expression and regulation in the human ovary.
Ota T; Asahina H; Park SH; Huang Q; Minegishi T; Auersperg N; Leung PC
Reprod Biol Endocrinol; 2008 Oct; 6():49. PubMed ID: 18973687
[TBL] [Abstract][Full Text] [Related]
28. Pre-B-cell leukemia transcription factor 1 regulates expression of valosin-containing protein, a gene involved in cancer growth.
Qiu Y; Tomita Y; Zhang B; Nakamichi I; Morii E; Aozasa K
Am J Pathol; 2007 Jan; 170(1):152-9. PubMed ID: 17200190
[TBL] [Abstract][Full Text] [Related]
29. Lack of association between NOTCH3 gene polymorphism and cerebrovascular disease in Japanese patients.
Mizuno T; Makino M; Fujiwara Y; Nakajima K
Ann N Y Acad Sci; 2002 Nov; 977():252-7. PubMed ID: 12480758
[No Abstract] [Full Text] [Related]
30. Deregulated expression of Notch receptors in human hepatocellular carcinoma.
Gao J; Song Z; Chen Y; Xia L; Wang J; Fan R; Du R; Zhang F; Hong L; Song J; Zou X; Xu H; Zheng G; Liu J; Fan D
Dig Liver Dis; 2008 Feb; 40(2):114-21. PubMed ID: 17920003
[TBL] [Abstract][Full Text] [Related]
31. Notch3 signaling initiates choroid plexus tumor formation.
Dang L; Fan X; Chaudhry A; Wang M; Gaiano N; Eberhart CG
Oncogene; 2006 Jan; 25(3):487-91. PubMed ID: 16186803
[TBL] [Abstract][Full Text] [Related]
32. Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis.
Bellavia D; Campese AF; Checquolo S; Balestri A; Biondi A; Cazzaniga G; Lendahl U; Fehling HJ; Hayday AC; Frati L; von Boehmer H; Gulino A; Screpanti I
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3788-93. PubMed ID: 11891328
[TBL] [Abstract][Full Text] [Related]
33. A study on Notch signaling in human breast cancer.
Zang S; Ji Ch; Qu X; Dong X; Ma D; Ye J; Ma R; Dai J; Guo D
Neoplasma; 2007; 54(4):304-10. PubMed ID: 17822320
[TBL] [Abstract][Full Text] [Related]
34. The epigenetic factor BORIS/CTCFL regulates the NOTCH3 gene expression in cancer cells.
Zampieri M; Ciccarone F; Palermo R; Cialfi S; Passananti C; Chiaretti S; Nocchia D; Talora C; Screpanti I; Caiafa P
Biochim Biophys Acta; 2014 Sep; 1839(9):813-25. PubMed ID: 24984200
[TBL] [Abstract][Full Text] [Related]
35. Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)-positive acute lymphoblastic leukaemias.
Paulsson K; Jonson T; Ora I; Olofsson T; Panagopoulos I; Johansson B
Br J Haematol; 2007 Jul; 138(2):196-201. PubMed ID: 17593026
[TBL] [Abstract][Full Text] [Related]
36. Constitutive activation of Notch3 inhibits terminal epithelial differentiation in lungs of transgenic mice.
Dang TP; Eichenberger S; Gonzalez A; Olson S; Carbone DP
Oncogene; 2003 Apr; 22(13):1988-97. PubMed ID: 12673204
[TBL] [Abstract][Full Text] [Related]
37. Conserved signal peptide of Notch3 inhibits interaction with proteasome.
Zhang Y; Jia L; Lee SJ; Wang MM
Biochem Biophys Res Commun; 2007 Mar; 355(1):245-51. PubMed ID: 17292860
[TBL] [Abstract][Full Text] [Related]
38. Functional diversity among Notch1, Notch2, and Notch3 receptors.
Shimizu K; Chiba S; Saito T; Kumano K; Hamada Y; Hirai H
Biochem Biophys Res Commun; 2002 Mar; 291(4):775-9. PubMed ID: 11866432
[TBL] [Abstract][Full Text] [Related]
39. Dominant-negative Notch3 receptor inhibits mitogen-activated protein kinase pathway and the growth of human lung cancers.
Haruki N; Kawaguchi KS; Eichenberger S; Massion PP; Olson S; Gonzalez A; Carbone DP; Dang TP
Cancer Res; 2005 May; 65(9):3555-61. PubMed ID: 15867348
[TBL] [Abstract][Full Text] [Related]
40. Notch signaling regulates platelet-derived growth factor receptor-beta expression in vascular smooth muscle cells.
Jin S; Hansson EM; Tikka S; Lanner F; Sahlgren C; Farnebo F; Baumann M; Kalimo H; Lendahl U
Circ Res; 2008 Jun; 102(12):1483-91. PubMed ID: 18483410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
